Hematopoietic engraftment of human embryonic stem cell-derived cells is regulated by recipient innate immunity

Keyphrases

• Innate Immunity 100%
• Stem Cell-derived 100%
• Human Embryonic Stem Cells (hESCs) 100%
• Hematopoietic Engraftment 100%
• Engraftment 50%
• Hematopoietic Cells 20%
• CD34+ Cells 20%
• Natural Killer Cells 10%
• Hematopoietic Stem Cells 10%
• Bone Marrow 10%
• Hematopoietic Development 10%
• Intra-bone Marrow Injection 10%
• Teratoma 10%
• Well-defined 10%
• Adaptive Immune Response 10%
• Host Immunity 10%
• Immune Effector Cells 10%
• Antiserum 10%
• Femur 10%
• Cell-derived 10%
• After Injection 10%
• Stromal Cells 10%
• Non-obese Diabetic 10%
• HLA Class I 10%
• CD45+ 10%
• SCID-repopulating Cell 10%
• Severe Combined Immunodeficient Mice 10%
• Mouse Bone Marrow 10%
• Innate Immune Effectors 10%

Immunology and Microbiology

• Engraftment 100%
• Innate Immune System 100%
• Human Embryonic Stem Cell 100%
• Hematopoietic Cell 30%
• CD34 20%
• Natural Killer Cell 10%
• Effector Cell 10%
• Antiserum 10%
• Immunity 10%
• SCID Mouse 10%
• NOD SCID Mouse 10%